Brandon Kwong

1.0k total citations
9 papers, 854 citations indexed

About

Brandon Kwong is a scholar working on Immunology, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Brandon Kwong has authored 9 papers receiving a total of 854 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Biomedical Engineering. Recurrent topics in Brandon Kwong's work include Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Brandon Kwong is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), RNA Interference and Gene Delivery (4 papers) and Nanoplatforms for cancer theranostics (4 papers). Brandon Kwong collaborates with scholars based in United States and France. Brandon Kwong's co-authors include Darrell J. Irvine, Haipeng Liu, S. Annie Gai, K. Dane Wittrup, Jamal Elkhader, Arpun R. Nagaraja, Yuhua Hu, Joshua S. Katz, Tamara R. Litwin and Nicki Watson and has published in prestigious journals such as Angewandte Chemie International Edition, Nano Letters and Nature Immunology.

In The Last Decade

Brandon Kwong

9 papers receiving 841 citations

Peers

Brandon Kwong
Lien Lybaert Belgium
Yonger Xue United States
Yudi Xu China
Ragy Ragheb United States
Karen Y. Dane United States
Miguel C. Sobral United States
Brandon Kwong
Citations per year, relative to Brandon Kwong Brandon Kwong (= 1×) peers Hathaichanok Phuengkham

Countries citing papers authored by Brandon Kwong

Since Specialization
Citations

This map shows the geographic impact of Brandon Kwong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brandon Kwong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brandon Kwong more than expected).

Fields of papers citing papers by Brandon Kwong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brandon Kwong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brandon Kwong. The network helps show where Brandon Kwong may publish in the future.

Co-authorship network of co-authors of Brandon Kwong

This figure shows the co-authorship network connecting the top 25 collaborators of Brandon Kwong. A scholar is included among the top collaborators of Brandon Kwong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brandon Kwong. Brandon Kwong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Kwong, Brandon, Joseph Banuelos, Petro Starokadomskyy, et al.. (2024). POS0462 PRECLINICAL DEVELOPMENT OF KYV-201, AN INVESTIGATIONAL ALLOGENEIC ANTI-CD19 CAR T CELL FOR THE TREATMENT OF AUTOIMMUNE DISEASE. Annals of the Rheumatic Diseases. 83. 1129–1130. 2 indexed citations
2.
Kwong, Brandon, Réjane Rua, Yuanyuan Gao, et al.. (2017). T-bet-dependent NKp46+ innate lymphoid cells regulate the onset of TH17-induced neuroinflammation. Nature Immunology. 18(10). 1117–1127. 90 indexed citations
3.
Kwong, Brandon, S. Annie Gai, Jamal Elkhader, K. Dane Wittrup, & Darrell J. Irvine. (2013). Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity. Cancer Research. 73(5). 1547–1558. 168 indexed citations
4.
Kwong, Brandon, S. Annie Gai, Jamal Elkhader, K. Dane Wittrup, & Darrell J. Irvine. (2013). Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity. DSpace@MIT (Massachusetts Institute of Technology). 52 indexed citations
5.
Kwong, Brandon, Haipeng Liu, & Darrell J. Irvine. (2012). Intratumoral delivery of liposome-anchored anti-CD137 and IL-2 induces highly potent local and systemic anti-tumor immunity while minimizing toxic inflammatory side effects (165.6). The Journal of Immunology. 188(1_Supplement). 165.6–165.6. 1 indexed citations
6.
Liu, Haipeng, Brandon Kwong, & Darrell J. Irvine. (2011). Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy. Angewandte Chemie International Edition. 50(31). 7052–7055. 119 indexed citations
7.
Kwong, Brandon, Haipeng Liu, & Darrell J. Irvine. (2011). Induction of potent anti-tumor responses while eliminating systemic side effects via liposome-anchored combinatorial immunotherapy. Biomaterials. 32(22). 5134–5147. 143 indexed citations
8.
Liu, Haipeng, Brandon Kwong, & Darrell J. Irvine. (2011). Membrane Anchored Immunostimulatory Oligonucleotides for In Vivo Cell Modification and Localized Immunotherapy. Angewandte Chemie. 123(31). 7190–7193. 19 indexed citations
9.
Hu, Yuhua, Tamara R. Litwin, Arpun R. Nagaraja, et al.. (2007). Cytosolic Delivery of Membrane-Impermeable Molecules in Dendritic Cells Using pH-Responsive Core−Shell Nanoparticles. Nano Letters. 7(10). 3056–3064. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026